OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comorbidities of sarcoidosis
Claudio Tana, Marjolein Drent, Hilario Nunès, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1014-1035
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Management of cardiac sarcoidosis
Rakesh Sharma, Vasileios Kouranos, Leslie T. Cooper, et al.
European Heart Journal (2024) Vol. 45, Iss. 30, pp. 2697-2726
Open Access | Times Cited: 15

Immune mechanisms in fibrotic interstitial lung disease
Mari Kamiya, Hannah M. Carter, Milena S. Espíndola, et al.
Cell (2024) Vol. 187, Iss. 14, pp. 3506-3530
Closed Access | Times Cited: 13

Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
Ogugua Ndili, Lesley Ann Saketkoo, Anne‐Marie Russell, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 32

Approach to COVID-19 in older adults and indications for improving the outcomes
Claudio Tana, Livia Moffa, Katia Falasca, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 14

Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry
Víctor Moreno‐Torres, María Martínez‐Urbistondo, Pedro Durán‐del Campo, et al.
Journal of Translational Autoimmunity (2024) Vol. 8, pp. 100236-100236
Open Access | Times Cited: 5

High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities
Dominique Israëł-Biet, Nicol Bernardinello, Jean Pastré, et al.
Diagnostics (2024) Vol. 14, Iss. 4, pp. 395-395
Open Access | Times Cited: 4

Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020
Fatima Ali Raza, Sumeet Kumar, Ayesha Mohammad, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317237-e0317237
Open Access

Proteome-wide mendelian randomization identifies causal plasma proteins in interstitial lung disease
Kunrong Yu, Wanying Li, Wenjie Long, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Sarcoidosis: molecular mechanisms and therapeutic strategies
Danfeng Xu, X. Tao, Yibin Fan, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access

Concurrent Pulmonary Sarcoidosis and Carcinomatous Lymphangitis
Hisako Kushima, Yoshiaki Kinoshita, Masayo Yoshimura, et al.
Internal Medicine (2025)
Open Access

Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review
Helena Buso, Claudia Discardi, Patrick Bez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1503-1503
Open Access | Times Cited: 3

Sarcoidosis and autoimmunity: In the depth of a complex relationship
Luigi Rizzi, Carlo Sabbà, Patrizia Suppressa
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13

Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation
Claudio Tana, Francesco Cinetto, Cesare Mantini, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2525-2525
Open Access | Times Cited: 13

Drug-induced comorbidities in patients with sarcoidosis
Marjolein Drent, Naomi T. Jessurun, Petal A. Wijnen, et al.
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 5, pp. 468-477
Open Access | Times Cited: 11

Infectious and non-infectious precipitants of sarcoidosis
O.S. Chioma, ZaDarreyal Wiggins, Samantha Rea, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103239-103239
Closed Access | Times Cited: 2

Reasons for Hospitalization and All-Cause Mortality for Adults with Sarcoidosis
Michael Manansala, Faria Sami, Shilpa Arora, et al.
American Journal of Medicine Open (2023) Vol. 9, pp. 100037-100037
Closed Access | Times Cited: 5

Common Clinical and Molecular Pathways between Migraine and Sarcoidosis
Claudio Tana, David García‐Azorín, Francesco Cinetto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8304-8304
Open Access | Times Cited: 4

Cardiac Involvement in Neurosarcoidosis
Sama Noroozi Gilandehi, Ka‐Ho Wong, Trieste Francis, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 1

Big data in sarcoidosis
Natalia V. Rivera
Current Opinion in Pulmonary Medicine (2024) Vol. 30, Iss. 5, pp. 561-569
Open Access | Times Cited: 1

The role of primary care in sarcoidosis
Vasileios Kouranos, Athol U. Wells
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 5, pp. 493-500
Closed Access | Times Cited: 3

Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging
Shinichi Kurashima, Takeshi Kitai, Αndrew Xanthopoulos, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 10, pp. 693-702
Closed Access | Times Cited: 2

Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study
Katharina Boch, Ewan A. Langan, Detlef Zillikens, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top